Effect of various decarboxylase inhibitors on the cerebral metabolism of dihydroxyphenylalanine
Effect of various decarboxylase inhibitors on the cerebral metabolism of dihydroxyphenylalanine
复制标题
各种脱羧酶抑制剂对二羟基苯丙氨酸脑代谢的影响
DOI:
--
复制
发表时间:
1969
期刊:
影响因子:
--
通讯作者:
A. Pletscher
中科院分区:
文献类型:
--
作者:
G. Bartholini;A. Pletscher
Small doses of Ro 44602 [N-(~~-seryl)-N’-(2,3,4-trihydroxybenzyl)hydrazine], an inhibitor of decarboxylase (DC), enhance the dopa-induced increase of catecholamines in the brain of rats. This was attributed to a poor penetration of the drug through the blood-brain barrier leading to a preferential inhibition of DC in extracerebral tissues like liver, heart and kidney. As a consequence, the concentration of administered dopa in plasma rose and the supply to the brain of this amino-acid was enhanced. This was followed by an increased formation of cerebral catecholamines and their metabolites, the phenolic carboxylic acids (Bartholini, Bates & others, 1967 ;. Bartholini & Pletscher, 1968 ; Bartholini, Tissot & Pletscher, 1968 ; Constantinidis, Bartholini & others, 1968). We now report the effect of some other known DC inhibitors : MK485 [~-(3,4-dihydroxyphenyl)-a-hydrazino-a-methyl propionic acid] ; NSD 101 5 (m-hydroxybenzylhydrazine) and a-methyldopa.